Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.02
42% from low
Exchange
OTC Link
OS
CHITOGENX INC
No one on the platform currently holds CHNXF.
No tracked institution reports a position in CHNXF as of their last filing.
No one on the platform has traded CHNXF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $0 | — | $0.49 | $0.49–$0.49 | 0.0× | 1 |
| 2028 | $0 | — | $1.34 | $1.34–$1.34 | 0.0× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 6 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2024-12-22 | $-0.01 | $-0.01 | -39.5% |
| 2024-09-27 | $-0.01 | $-0.00 | +60.2% |
| 2024-07-02 | $-0.01 | $-0.00 | +86.1% |
| 2024-04-03 | $-0.01 | $-0.00 | +72.5% |
| 2024-01-03 | $-0.01 | $-0.01 | +0.0% |
| 2023-09-29 | $-0.02 | $-0.01 | +50.0% |
| 2023-06-29 | $-0.02 | $-0.02 | +0.0% |
| 2022-12-28 | $-0.02 | $-0.03 | -36.3% |
| $90309 |
| — |
| NBIONascent Biotech, Inc. | $0.00 | +0.00% | $51665 | — |
| RASPActavia Life Sciences, Inc. | $0.00 | +0.00% | $385906 | — |
Source: Financial Modeling Prep · peers by sector/industry
$CHNXF CHITOGENX LAUNCHES BURN AND SKIN REPAIR DEVELOPMENT PROGRAM https://www.stocktitan.net/news/CHNXF/chitogenx-launches-burn-and-skin-repair-development-cuo3ivd0ab32.html
View on StockTwits ↗Noble Capital Markets Research Report: ChitogenX Inc. (CHNXF) – Non-Brokered Private Placement 2nd Tranche Closed; Clarification And Revision $CHNXF https://www.channelchek.com/news-channel/chitogenx-inc-chnxf-non-brokered-private-placement-2nd-tranche-closed-clarification-and-revision
View on StockTwits ↗Noble Capital Markets Research Report: ChitogenX Inc. (CHNXF) – FY2023 Ending January 31, 2023 Reported $CHNXF https://www.channelchek.com/news-channel/chitogenx-inc-chnxf-fy2023-ending-january-31-2023-reported
View on StockTwits ↗Noble Capital Markets Research Report: ChitogenX Inc. (CHNXF) – Third Time’s the Charm? Non-Brokered Private Placement Terms Amended Again $CHNXF https://www.channelchek.com/news-channel/chitogenx-inc-chnxf-third-times-the-charm-non-brokered-private-placement-terms-amended-again
View on StockTwits ↗Noble Capital Markets Research Report: ChitogenX Inc. (CHNXF) – New Private Placement Offering Announced $CHNXF https://www.channelchek.com/news-channel/chitogenx-inc-chnxf-new-private-placement-offering-announced
View on StockTwits ↗Noble Capital Markets Research Report: ChitogenX Inc. (CHNXF) – Grant Awarded to Develop New Opportunities and Indications $CHNXF https://www.channelchek.com/news-channel/chitogenx-inc-chnxf-grant-awarded-to-develop-new-opportunities-and-indications
View on StockTwits ↗Noble Capital Markets Research Report: ChitogenX Inc. (CHNXF) – Proof of Concept Confirmed in Meniscus Tear Repair Study $CHNXF https://www.channelchek.com/news-channel/chitogenx-inc-chnxf-proof-of-concept-confirmed-in-meniscus-tear-repair-study
View on StockTwits ↗Noble Capital Markets Research Report: ChitogenX Inc. (CHNXF) – Offering Announced; Increasing Price Target $CHNXF https://www.channelchek.com/news-channel/chitogenx-inc-chnxf-offering-announced-increasing-price-target
View on StockTwits ↗Noble Capital Markets Research Report: ChitogenX Inc. (CHNXF) – FQ3 2023 Reported; Advancing The Opportunities $CHNXF https://www.channelchek.com/news-channel/chitogenx-inc-chnxf-fq3-2023-reported-advancing-the-opportunities
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.